Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Hanna, CR; O'Cathail, SM; Graham, JS; Saunders, M; Samuel, L; Harrison, M; Devlin, L; Edwards, J; Gaya, DR; Kelly, CA; Lewsley, LA; Maka, N; Morrison, P; Dinnett, L; Dillon, S; Gourlay, J; Platt, JJ; Thomson, F; Adams, RA; Roxburgh, CSD

Hanna, CR (corresponding author), Univ Glasgow, Inst Canc Sci, Beatson West Scotland Canc Ctr, Canc Res UK Glasgow Clin Trials Unit, Level 0,1053 Great Western Rd, Glasgow G12 0YN, Lanark, Scotland.

RADIATION ONCOLOGY, 2021; 16 (1):

Abstract

Background Advances in multi-modality treatment of locally advanced rectal cancer (LARC) have resulted in low local recurrence rates, but around 30% o......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索